Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Clinical Therapeutics|November 9, 2004
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trialPeter H Jones, Donald B Hunninghake, Keith C Ferdinand, et al.
Clinical Chemistry|June 25, 2005
Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 systemMine Y Liu, Antonios M Xydakis, Ron C Hoogeveen, et al.
Atherosclerosis|September 6, 2011
Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemiaAriel Brautbar, Daniel Covarrubias, John Belmont, et al.
Atherosclerosis|January 24, 2007
Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)James M McKenney, Peter H Jones, Harold E Bays, et al.
Journal of Clinical Lipidology|June 1, 2019
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid AssociationDon P Wilson, Terry A Jacobson, Peter H Jones, et al.
American Heart Journal|October 12, 2010
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemiaPeter H Jones, Anne C Goldberg, Howard R Knapp, et al.
Journal of Clinical Lipidology|September 6, 2022
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid AssociationDon P Wilson, Terry A Jacobson, Peter H Jones, et al.
Atherosclerosis|February 10, 2009
Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levelsSeiko Otokozawa, Masumi Ai, Thomas Van Himbergen, et al.
The American Journal of Cardiology|February 24, 2007
Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteinsBela F Asztalos, Florence Le Maulf, Gerald E Dallal, et al.
The American Journal of Cardiology|January 25, 2011
Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammationNuntakorn Thongtang, Masumi Ai, Seiko Otokozawa, et al.
Pageof 10